Private Equity, VC & Investor
Breega vs IRIS
Structured technology and market comparison · 2026
Direct Feature Comparison
Breega · vs · IRISEuropean and African early-stage venture capital fund manager.
European venture capital firm for technology startups and growth companies.
Analyze all overlapping signals and tech stacks for Breega and IRIS
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Breega and IRIS?
When comparing Breega and IRIS, both platforms operate within the Private Equity, VC & Investor ecosystem. Breega is positioned as European and African early-stage venture capital fund manager, whereas IRIS focuses on European venture capital firm for technology startups and growth companies. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Breega and IRIS?
When evaluating Breega and IRIS, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Breega and IRIS compare?
Breega is headquartered in FR (founded in 2013) with 10–49 employees. IRIS is based in FR (founding year unrecorded) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Breega vs IRIS
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
IRIS
Recent Signals
- ·Tech.eu (European Tech & Deals)Infrastructure
Vates raises €30M from IRIS and Bpifrance
French virtualization company Vates has raised €30 million in growth funding from IRIS' Growth fund and Bpifrance's Large Venture fund. The investment comes amid shifts in the global virtualization market, driven by licensing changes, rising infrastructure costs, and complex architectures. Vates offers an open-source virtualization platform designed to give organizations control, reduce technological dependency, and ensure interoperability and reversibility. The company has expanded internationally, with customers in 100 countries and North America as its largest market. It also joined Gartner's Magic Quadrant for virtualization in 2026. The funding will accelerate Vates' strategy, focusing on next-generation platform development, international expansion in North America and Europe, and building a partner ecosystem. Open source remains central to Vates' approach.
- Vates raised €30 million from IRIS' Growth fund and Bpifrance's Large Venture fund.
- Vates serves customers in 100 countries, with North America as its largest market.
- Vates joined Gartner's Magic Quadrant for virtualization in 2026.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Breega and IRIS share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks